Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:2387-2388

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cottin, Y.
Right arrow Articles by Wolf, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cottin, Y.
Right arrow Articles by Wolf, J. E.

(Circulation. 1999;100:2387.)
© 1999 American Heart Association, Inc.


Images in Cardiovascular Medicine

Somatostatin-Receptor Scintigraphy Identifies a Cardiac Pheochromocytoma

Yves Cottin, MD; Alina Berriolo, MD; France Guy, MD; Michel Toubeau, MD; Ivan Belleville, MD; Roger Brenot, MD; François Brunotte, MD; Jean Eric Wolf, MD

From the Department of Cardiology, the Division of Nuclear Medicine, the Department of Radiology, the Division of Endocrinology, and the Division of Magnetic Resonance, Centre Hospitalier Universitaire et Centre G.F. Leclerc, Dijon, France.

Correspondence to Dr Yves Cottin, Service de cardiologie II, Centre Hospitalier Universitaire, 2 boulevard Maréchal de Lattre de Tassigny, 210134 Dijon Cedex, France.

A17-year-old woman had paroxysmal hypertension. Very high levels of urinary catecholamines suggested a diagnosis of pheochromocytoma (urinary norepinephrine 27 600 nmol/24 hours, normal <485 nmol/24 hours; urinary normetanephrine 37 607 nmol/24 hours, normal <2000 nmol/24 hours), but no adrenal tumor was found on the abdominal CT scan. Metaiodobenzylguanidine (MIBG) whole-body scintigraphy was performed, and no abnormal uptake was observed. To locate the tumor, 111In-labeled pentetreotide somatostatin-receptor scintigraphy was performed. An intense focal uptake was seen in the thoracic area (Figure 1Down). An intravenous injection of 99mTc microspheres was used to label the lungs. The subsequent double-isotope tomoscintigraphy located the tumor beside the right lung in the inferior mediastinum (Figure 1Down).



View larger version (111K):
[in this window]
[in a new window]
 
Figure 1. Whole-body scintigraphy 48 hours after the administration of 185 MBq of 111In-pentetreotide. Anterior and posterior views reveal a focal uptake above the liver. A transaxial slice acquired by double-isotope single photon emission CT shows that the tumor labeled with 111In pentetreotide (red) is in the mediastinum beside the right lung, which is labeled with 99mTc microspheres (green).

ECG-gated MRI and transesophageal echocardiography gave further information about the anatomic extent of the tumor. The pheochromocytoma was located adjacent to the right atrium (Figure 2Down).



View larger version (74K):
[in this window]
[in a new window]
 
Figure 2. A T1-weighted black-blood spin-echo axial MRI slice (left) shows the pheochromocytoma as a bright tumor adjacent to the right atrial free wall and to the right lung. A breathhold bright-blood cine-MRI oblique slice (right) shows the tumor extending behind the superior vena cava.

The patient underwent surgical removal of the tumor and had . . . [Full Text of this Article]